Cáncer renal subgrupos de pacientes y poblaciones especiales: ¿qué hemos aprendido? - page 74

Armstrong AJ, et al. Lancet Oncol 2016;17:378‐88

Hypothesis:

HR 1.60 (PFS 6.0

9.6 mo; 83% power; two‐sided type 1 error rate, 0.20

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,64,65,66,67,68,69,70,71,72,73 75,76,77,78,79,80,81,82,83,...84